Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to come.

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer recurring in patients who initially respond.

"It's really exciting, because when we talk about curing cancer, it's not really a single monolithic disease," he added. "There are probably hundreds of different targets for ever

As per a new study, the potential of mRNA vaccines offers a personalized treatment for patients with pancreatic cancer.